In vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated falciparum malaria in children: a multisite, open-label, two-cohort, clinical trial in Mozambique

Background: Mozambique adopted artemisinin-based combination therapy (ACT) for the treatment of uncomplicated Plasmodium falciparum malaria in the year 2006, and since 2009 artemether-lumefantrine (AL) and artesunate- amodiaquine (ASAQ) have been proposed as alternative first-line treatments. A mult...

Full description

Bibliographic Details
Main Author: Nhama, Abel (author)
Other Authors: Bassat, Quique (author), Enosse, Sónia (author), Nhacolo, Arsenio (author), Mutemba, Rosália (author), Carvalho, Eva (author), Sevene, Esperança (author), Guinovart, Caterina (author), Warsame, Marian (author), Sanz, Sergi (author), Mussa, Abdul (author), Matsinhe, Graça (author), Alonso, Pedro L. (author), Tiago, Armindo (author), Macete, Eusébio (author)
Format: article
Language:eng
Published: 2021
Subjects:
Malaria in children
Plasmodium falciparum
Online Access:https://pubmed.ncbi.nlm.nih.gov/25108397/
http://www.repositorio.uem.mz/handle/258/462
Country:Mozambique
Oai:oai:www.repositorio.uem.mz:258/462

Internet

https://pubmed.ncbi.nlm.nih.gov/25108397/
http://www.repositorio.uem.mz/handle/258/462

Similar Items